Highlights

  • Amaero (ASX:3DA) continues to expand its advanced materials Business through US defence and aerospace opportunities.
  • FY2026 Revenue increased significantly as Manufacturing capacity and contract activity expanded.
  • The company is progressing a US-focused strategy supported by its Tennessee Facility and proposed Nasdaq listing pathway.
  • Amaero remains focused on scaling production while managing funding and execution challenges.

Amaero Inc. (ASX:3DA), formerly known as Amaero International Ltd, is progressing its transition into a US-focused advanced materials manufacturer following its Delaware re-domiciliation and continued expansion across defence and aerospace applications. The company’s strategy centres on producing specialised metal powders used in high-performance applications, including aerospace, defence and industrial technologies.

The company has continued to build its presence within the US advanced manufacturing ecosystem through new defence-related contracts, expanded manufacturing capacity and steps towards a potential Nasdaq listing. However, Amaero remains in an early growth phase, with profitability, production execution and funding requirements continuing to be important considerations.

What Just Happened?

Amaero completed its transition to a Delaware-domiciled company in June 2026, with its ASX securities now trading as CHESS Depositary Interests under the ticker (ASX:3DA). The structural change was designed to align the company more closely with its primary operating market, customers and strategic partners in the United States.

The company’s FY2026 results highlighted substantial revenue growth, supported by increased manufacturing activity and contract progress. Amaero reported FY2026 revenue of A$18.1 million, compared with A$3.8 million in FY2025, while continuing to invest in production expansion and operational capability.

During the year, Amaero also progressed several defence-related initiatives, including a US Department of War contract announced in July 2026, board changes to support US defence requirements and a confidential filing related to a potential US listing.

Digging Into the Numbers

Amaero reported FY2026 revenue of A$18.1 million, representing significant growth from the prior year. The company’s order Backlog increased to A$14.6 million as at 30 June 2026 and later expanded to A$23.1 million following additional contract wins.

The company reported that A$12.9 million of the backlog was expected to be delivered by 31 December 2026, providing visibility over near-term production activity.

Manufacturing capacity has also expanded. Amaero commissioned a third EIGA (electrode induction-melting gas atomisation) atomiser at its Tennessee facility in June 2026, increasing titanium powder production capacity to approximately 480 metric tonnes annually. The facility also has refractory alloy capacity of approximately 200 tonnes.

Amaero’s US Export-Import Bank facility was expanded from US$22.8 million to US$26.1 million during June 2026, supporting ongoing manufacturing development.

Despite revenue growth, the company remains pre-profit. Amaero reported a FY2026 net loss of A$36.5 million, reflecting continued Investment in manufacturing expansion, operational development and business scaling.

Production was also temporarily affected by safety incidents during May 2026, with titanium production resuming in July. The company stated that no customer orders were cancelled during the disruption, although the event highlighted the operational challenges involved in scaling specialised manufacturing.

Why the Market Is Paying Attention

Amaero operates at the intersection of advanced manufacturing, defence Supply chains and critical materials production. Its Tennessee facility produces titanium and refractory alloy powders used in applications such as aerospace components, defence systems and high-temperature industrial environments.

The company received a US Department of War contract valued at approximately A$6.5 million to develop alternative high-temperature refractory alloy powders. The agreement is focused on supporting advanced materials development for defence applications.

Amaero also received a smaller contract related to submarine industrial base requirements, further expanding its involvement in US defence-linked manufacturing programs.

The company’s US-focused strategy has also influenced its corporate structure. Amaero’s board transition towards a fully US-based structure was designed to support alignment with Foreign Ownership, Control or Influence (FOCI) requirements relevant to US defence industry participation.

The Bigger Story

Amaero’s strategic shift reflects a broader effort by governments and industries to strengthen domestic supply chains for critical materials and advanced manufacturing capabilities.

The company’s Delaware re-domiciliation and proposed Nasdaq listing pathway are intended to position Amaero closer to its key customers, funding partners and strategic opportunities in the US market.

In July 2026, Amaero confidentially submitted a draft Form S-1 registration statement with the US Securities and Exchange Commission for a potential Nasdaq listing. The company indicated that timing would depend on regulatory review and market conditions.

A US listing could provide additional market exposure and align Amaero with a broader investor base focused on defence technology and advanced manufacturing. However, maintaining operations across multiple markets may introduce additional complexity around liquidity, reporting requirements and Shareholder engagement.

What Investors Should Watch Next

  • Progress of the proposed Nasdaq listing process and regulatory review.
  • Conversion of the existing backlog into recognised revenue.
  • Ability to scale production while maintaining operational reliability.
  • Further defence and aerospace contract opportunities.
  • Cash position and funding requirements as the company continues expansion.

Conclusion

Amaero (ASX:3DA) is advancing its transformation from an advanced materials producer into a US-focused defence manufacturing company. Revenue growth, expanding backlog and new defence-related opportunities highlight progress in commercial development.

However, the company remains in a growth phase, with profitability yet to be established and execution challenges continuing as manufacturing capacity expands. Future performance will depend on converting contract opportunities into sustainable revenue while maintaining disciplined Capital management and operational delivery.